Fatigue has many possible causes. NAD+ and glutathione may be interesting biologically, but they should not replace a thoughtful medical evaluation.
Staging approval
Review this article
Use this staging form to record Dr. Mueller’s decision for “Fatigue, NAD+, and Glutathione: What to Check Before Choosing a Therapy.”
Begin with the pattern of fatigue
Useful questions include when the fatigue began, whether it is constant or episodic, how sleep feels, which medications or supplements changed, and whether weight, mood, exercise tolerance, pain, bleeding, fever, shortness of breath, or other symptoms changed with it.
Evaluation may consider sleep disorders, anemia, thyroid disease, diabetes, nutritional deficiencies, depression, infection, medication effects, and other causes based on the person’s history and examination.
What NAD+ research can and cannot show
NAD+ is essential to energy metabolism and cellular signaling. Human studies of precursors such as NMN and NR show that some interventions can raise NAD-related biomarkers, but clinical outcomes remain mixed and differ from direct IV or injectable NAD+ claims.
A short study showing improved laboratory levels does not establish that a product cures fatigue, reverses aging, or extends life. Route, dose, formulation, study duration, participant health, and conflicts of interest all matter.
Where glutathione fits
The body produces glutathione and uses it in normal antioxidant systems. Evidence for supplementation or infusion is condition- and route-specific; broad ‘detox,’ energy, skin, and longevity promises should be evaluated separately rather than bundled together.
A responsible plan treats a correctable cause when one is found, reinforces sleep, nutrition, movement, and medication review, and adds a therapy only when the expected benefit can be explained and measured.